Yep agreed @prosperityHere are my notes, originally posted on my...

Yep agreed @prosperity

Here are my notes, originally posted on my substack.

Whilst I wouldn’t necessarily say that breast imaging analytics software provider Volpara knocked it out the park, seeing a second consecutive quarter of positive cashflow (even if slim) was a very pleasant surprise.

My quick, back of the napkin math leads me to 17% annualised growth in Contracted Annual Recurring Revenue. This is the primary growth metric I use for them given it’s the lead indicator of ARR to come in the future. ARR growth was at ~25% annualised, showing me they implemented faster than they closed. The strategy of targeting bigger accounts for larger deals seems to be paying off, and the new CEO seems to be wining hearts and minds with her quirky leadership style.

Also one to watch in the future, let’s see full year report when it comes out in a few weeks.